CategoryMedical & Pharma
CPhI Middle East & Africa
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to CPhI Middle East & Africa — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
CPHI Middle East 14–16 December 2026
CPHI Middle East & Africa is a leading pharmaceutical industry event bringing together pharmaceutical and biotech companies to connect, network, and explore innovations across the global supply chain. Scheduled for 14–16 December 2026, the event will take place at the Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia.
Event overview
CPHI Middle East is positioned as a major meeting point for stakeholders operating within the pharmaceutical ecosystem—supporting business relationships, market access, and supply chain partnerships in one of the region’s most important pharma markets. The event provides extensive networking opportunities, direct market access, and targeted industry insights focused on regulatory developments and pharmaceutical innovation.
Why attend (what to expect)
- Large-scale pharma and biotech participation: The event is expected to bring together 1,000+ exhibiting brands.
- High international reach: Participation includes 110+ countries.
- Strong content and expert speaking faculty: Attendees can expect 310+ expert speakers.
- Substantial visitor volume: The event forecasts 60,000 visitors.
- Comprehensive coverage of the pharma value chain: Exhibitors and partners span multiple pharma industry sectors, supporting discovery of new products, services, and collaborations across the market.
Key industry sectors represented
Exhibitors are organized across multiple tracks covering essential segments of the pharmaceutical industry. The core sectors highlighted include:
- Machinery & equipment
- Finished dosage
- Packaging & drug delivery
- Contract services
- API
- Excipients
- Integrated pharma
- Natural extracts
- Fine chemicals
Business and networking focus
The event is designed to help industry participants turn connections into commercial opportunity. Attendees typically come to build relationships across regional networks while accessing the broader global supply chain. Through both in-person interactions and year-round digital engagement, stakeholders are supported in maintaining and expanding partnerships over time.
Location and dates
Dates: 14–16 December 2026
Venue: Riyadh Exhibition and Convention Centre, Malham
Country: Saudi Arabia
How the event is structured (high-level)
CPHI Middle East includes opportunities for industry knowledge exchange and business development through: a curated speaker program, expo participation, and structured networking engagement. The agenda also supports awareness of pharmaceutical trends and regulatory themes relevant to the region and the global industry.
Bottom line
For companies seeking regional market access and global partnership opportunities in pharma, CPHI Middle East & Africa (Riyadh, 14–16 December 2026) offers a concentrated platform to meet decision-makers, discover new solutions across the supply chain, and engage with a highly international pharma and biotech community.
Data sheet
CPhI Middle East & Africa – Event Attendee & Buyer Profile Analysis
Event Date: 14–16 December 2026 |
Location: Riyadh, Saudi Arabia |
Event Status: Upcoming |
Research Date: 30 June 2026
Event Overview
| Event Name | CPhI Middle East & Africa |
| Event Date | 14–16 December 2026 |
| Event Status | Upcoming |
| Venue | Riyadh Exhibition and Convention Centre, Malham |
| City | Riyadh |
| State / Region | Riyadh Province |
| Country | Saudi Arabia |
| Organizer | Informa Markets / Informa PLC |
| Official Event Website | cphi.com/middle-east/ |
| Event Type | Pharmaceutical supply chain exhibition, conference, networking, and sourcing event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Business Services; Logistics & Transportation; Industrial Engineering |
| Audience Reach | Global, with strong Middle East and Africa buyer concentration |
| Estimated Attendance / Expected Footfall | 60,000 visitors (organizer-reported) |
| Attendance Data Reliability | Confirmed by organizer marketing copy on the official website; treat as organizer-published expectation for the 2026 edition |
| Main Purpose of Event | To connect pharmaceutical and biotech companies, promote sourcing and partnerships, showcase innovations, and enable networking across the pharma supply chain |
About the Event
CPhI Middle East & Africa is a major pharmaceutical industry meeting in Riyadh that brings together suppliers, manufacturers, innovators, and commercial decision-makers across the pharma value chain. The official 2026 positioning emphasizes “the Middle East and Africa’s largest pharma market,” with a strong focus on networking, market access, regulatory insight, and supply-chain engagement.
The event matters because it sits at the intersection of procurement, manufacturing, formulation, packaging, contract services, and market development. It is highly relevant for companies seeking buyers, channel partners, distributors, contract manufacturers, service providers, and government-related healthcare stakeholders across Saudi Arabia, the GCC, and wider MENA and African markets.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Procurement and sourcing teams | Pharma manufacturers, CDMOs, distributors, healthcare groups | Owns supplier selection, pricing, RFQs, and vendor onboarding | High-value audience for APIs, excipients, packaging, and contract services |
| Manufacturing and operations leaders | Drug manufacturers, sterile fill-finish, dosage-form producers | Influence equipment, process, quality, and capacity investments | Relevant for machinery, automation, and process technology suppliers |
| Quality, regulatory, and compliance teams | Pharma QA/QC, regulatory affairs, validation, pharmacovigilance | Influence approved supplier lists and product compliance decisions | Key audience for compliant suppliers and documentation-heavy offerings |
| Business development and partnerships teams | Pharma companies, biotech firms, CDMOs, distributors | Evaluates alliances, licensing, and market-entry opportunities | Strong for service providers, market access, and contract manufacturing leads |
| R&D, formulation, and product development teams | Innovator pharma, generics, biosimilars, ingredient suppliers | Specify ingredients, delivery systems, and development partners | Relevant for APIs, excipients, drug delivery, and formulation technologies |
| Distribution and wholesale buyers | Regional wholesalers, importers, pharmacy distributors | Influence product onboarding, channel access, and pricing | Important for brands seeking regional market access |
| Government and public-sector health stakeholders | Health authorities, regulators, public hospitals, procurement offices | Influence tendering, policy, registration, and public purchasing | Relevant for suppliers targeting public healthcare supply chains |
| Investors and strategic partners | Private equity, venture capital, corporate development teams | Assess growth, licensing, and acquisition opportunities | Useful for innovation, scale-up, and partnership pipelines |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Riyadh | Saudi-based pharma, healthcare, government, logistics, and distributor stakeholders | Very high | Core audience because the event is hosted in the Saudi market center |
| Host region: Riyadh Province / Central Saudi Arabia | Regional manufacturers, importers, wholesalers, hospital buyers, public-sector agencies | High | Includes companies with direct supply-chain and tendering influence |
| Nearby business hubs | Jeddah, Dammam/Khobar, NEOM-linked projects, GCC trade centers | High | Likely draw for regional sourcing, operations, and distribution teams |
| National reach: Saudi Arabia | Pharma manufacturers, hospital systems, government buyers, distributors, labs | Very high | Saudi pharma market access is a central event theme |
| Regional reach: GCC and MENA | Distributors, importers, contract manufacturers, regulatory and procurement teams | High | Strong fit for supplier and buyer networking across trade corridors |
| International reach | Global pharma and biotech companies from 110+ countries | High | Organizer states 110+ countries; global sourcing relevance is strong |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | Official website states participation from 110+ countries and positions the event as a global pharma community platform. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Bayer | Global pharma / healthcare manufacturer | Relevant for pharmaceutical sourcing, partnerships, digital and quality leadership; listed speaker organization on official site | bayer.com | VP Procurement, Director of Strategic Sourcing, CIO, Head of Quality | Confirmed Speaker Organization |
| GSK | Global pharma manufacturer | Buyer for APIs, packaging, contract services, quality systems, and regional distribution partnerships | gsk.com | Director Procurement, Supply Chain Director, Quality Director, Business Development Director | Confirmed Speaker Organization |
| Lonza | CDMO / pharma services | High relevance for contract manufacturing, ingredients, packaging, and outsourcing decisions | lonza.com | Head of Procurement, Head of Partnerships, Operations Director, Program Manager | Confirmed Speaker Organization |
| WuXi Biologics | Biologics development and manufacturing | Relevant for biologics partnerships, process technology, and regional expansion | wuxibiologics.com | Business Development Director, Supply Chain Director, Procurement Manager, Technical Operations Lead | Confirmed Speaker Organization |
| Marken (UPS Healthcare) | Pharma logistics / cold chain | Relevant for distribution, specialty logistics, and temperature-controlled supply chain needs | marken.com | Logistics Director, Supply Chain Director, Operations Director, Procurement Lead | Confirmed Speaker Organization |
| DHA (Dubai Health Authority) | Government health authority | Public-sector healthcare stakeholder with procurement, policy, and market access relevance | dha.gov.ae | Procurement Officer, Contracting Officer, Public Health Program Manager, Regulatory Lead | Confirmed Speaker Organization |
| IQVIA | Healthcare analytics / consulting | Knowledge partner with strong market intelligence influence; relevant to pharma strategy and market entry | iqvia.com | Market Access Director, Strategy Director, Insights Director, Consulting Partner | Confirmed Partner / Knowledge Partner |
| Tahaluf | Event alliance / ecosystem organizer | Organizer ecosystem with access to pharma, health, and technology buyers in the region | tahaluf.com | Partnerships Director, Sponsorship Manager, Business Development Director | Confirmed Brand / Alliance Context |
| Saudi Food and Drug Authority (SFDA) | Government regulator | Core regulatory stakeholder for pharma registration, compliance, and market access in Saudi Arabia | sfda.gov.sa | Regulatory Affairs Director, Policy Lead, Procurement Officer, Public Sector Manager | Confirmed Government / Procurement Organization |
| Gilead Sciences | Pharma manufacturer | Relevant for partnerships, distribution, regulatory, and procurement engagement in regional markets | gilead.com | Business Development Director, Procurement Lead, Regional Market Access Lead | Prior-Year Participation Evidence |
| Pfizer | Pharma manufacturer | Strong strategic fit for sourcing, market access, and partnership discussions | pfizer.com | Director Procurement, Supply Chain Director, Country Manager, Partnerships Director | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharma manufacturer | Relevant for regional commercial, supply chain, and innovation conversations | novartis.com | Procurement Director, Supply Chain Director, Medical Affairs Lead, BD Director | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharma manufacturer | High relevance for biotech, commercialization, and supply chain partnerships | astrazeneca.com | VP Procurement, Director of Partnerships, Operations Director, Market Access Lead | Strong Market Fit, Attendance Not Confirmed |
| AbbVie | Pharma manufacturer | Potential buyer for supply chain, packaging, and regional distribution opportunities | abbvie.com | Procurement Manager, Supply Chain Director, Commercial Director | Strong Market Fit, Attendance Not Confirmed |
| Thermo Fisher Scientific | Life sciences tools / lab supply | Relevant for lab, research, and pharma manufacturing ecosystem spend | thermofisher.com | Sales Director, Category Manager, Procurement Lead, Lab Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Sandoz | Generics / biosimilars manufacturer | Fits the event’s generics and biosimilars market direction noted in the organizer’s content | sandoz.com | Procurement Director, Business Development Director, Supply Chain Lead | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Procurement Officer / VP Procurement | Procurement | C-level / VP | Owns sourcing strategy, supplier selection, and vendor consolidation |
| 2 | Director of Procurement / Strategic Sourcing Manager | Sourcing | Director / Manager | Evaluates suppliers for APIs, packaging, and services |
| 3 | Supply Chain Director / Logistics Manager | Supply Chain | Director / Manager | Important for inbound materials, warehousing, and distribution |
| 4 | Quality Director / Regulatory Affairs Director | Quality / Regulatory | Director | Controls compliance, registration, and supplier qualification |
| 5 | Business Development Director / Partnerships Director | Commercial / Partnerships | Director | Drives alliances, market entry, and regional expansion |
| 6 | Operations Director / Plant Manager | Operations / Manufacturing | Director / Senior Manager | Influences equipment, throughput, and production investments |
| 7 | CIO / CTO / IT Director | IT / Digital | C-level / Director | Relevant for digital supply chain, quality systems, and analytics |
| 8 | Product Development / Formulation Lead | R&D | Manager / Director | Needs ingredients, delivery systems, and development partners |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core industry focus of the event | Drug manufacturers, buyers, and commercial leaders |
| 2 | Biotechnology | Strong biotech participation and innovation content | Biologics, R&D, and partnership targets |
| 3 | Medical Devices | Adjacent healthcare procurement ecosystem | Healthcare supply-chain buyers and hospital groups |
| 4 | Logistics & Supply Chain | Cold chain, warehousing, and distribution are highly relevant | Importers, distributors, logistics providers |
| 5 | Biotechnology Research | Innovation and advanced manufacturing focus | R&D decision-makers and technical buyers |
| 6 | Medical Practice | Relevant for healthcare procurement and market access | Hospital and clinic procurement stakeholders |
| 7 | Government Administration | Public-sector health and regulatory buyers attend or engage | Regulators, public procurement, ministries |
| 8 | Information Technology & Services | Digital supply chain, QA systems, and analytics relevance | IT leaders in pharma and healthcare |
| 9 | Wholesale | Distributors and wholesalers are important commercial attendees | Importer/distributor buying teams |
| 10 | Market Research | Market intelligence and competitive insight are core event outputs | Insights, strategy, and commercial teams |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | 60,000 visitors | Confirmed by organizer | Official website event overview for 2026 | Use as organizer-published expected attendance |
| Exhibiting brands | 1,000+ | Confirmed by organizer | Official website event overview for 2026 | Exhibitor participation is a strong prospecting pool |
| Countries represented | 110+ | Confirmed by organizer | Official website event overview for 2026 | Supports global audience classification |
| Expert speakers | 310+ | Confirmed by organizer | Official website event overview for 2026 | Speaker list useful for account mapping |
| Historical attendance context | 30,000+ visitors at 2024 edition | Historical / prior-year evidence | Official website 2026 copy referencing breakout 2024 edition | Useful benchmark; not current-year registration data |
| Buyer count | Not publicly confirmed by the organizer | Unavailable | No official current-year buyer count published in supplied source text | Use attendee segmentation instead of a buyer-total claim |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Procurement | Qualified suppliers, price competitiveness, reliability | RFQ meetings, supplier qualification, account mapping | APIs, excipients, packaging, contract services |
| Regulatory / Compliance | Documentation, approvals, market entry support | One-to-one meetings with QA and RA stakeholders | Regulatory consulting, validation, compliant packaging |
| Manufacturing Technology | Higher throughput, lower waste, better efficiency | Equipment demos, process optimization discussions | Machinery, automation, process systems |
| Biologics / Innovation | Advanced development, partnership, scale-up support | Executive networking and innovation showcases | CDMO services, biologics platforms, analytical services |
| Packaging & Drug Delivery | Safe, compliant, scalable packaging solutions | Supplier discovery and packaging innovation discussions | Primary and secondary packaging, device components |
| Supply Chain / Logistics | Cold chain, import/export, lead-time management | Logistics partner meetings and regional distribution planning | Cold chain logistics, warehousing, freight forwarding |
| Market Access | Local channel partners and regulatory navigation | Regional commercial meetings and distributor outreach | Distribution, localization, market research |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Pharma buyers, sourcing teams, and regulators are core to the event’s purpose. |
| Decision-maker availability | High | The show format and speaker roster suggest strong executive and director-level presence. |
| Data collection potential | High | Exhibitor list, speaker list, and sector tracks provide useful account-building inputs. |
| Apollo targeting potential | Very High | Clear industry, department, seniority, and title filters are available for pharma targeting. |
| Geographic targeting potential | High | Saudi Arabia, GCC, and broader MENA filters are highly relevant. |
| Best outreach approach | Account-based outreach | Target procurement, commercial, and operations leaders with event-specific messaging. |
| Overall lead quality | Very High | Strong B2B attendee-list potential for pharma, biotech, logistics, and healthcare supplier campaigns. |
| Best use case | Lead generation / attendee intelligence / sponsorship prospecting | Excellent for supplier targeting, list-building, and pipeline development. |
| Limitations / risks | Attendance list not publicly confirmed | Some sample companies are strong-fit targets rather than confirmed attendees; use evidence labels carefully. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Biotechnology; Medical Devices; Logistics & Supply Chain; Government Administration; Information Technology & Services; Market Research | Focus on core buyers and adjacent stakeholders |
| Departments | Procurement; Operations; Supply Chain; Quality; Regulatory Affairs; Business Development; Product; IT | Reach the functions most likely to buy or influence sourcing |
| Seniority | Manager; Director; VP; C-Level; Head | Prioritize decision-makers and budget owners |
| Job titles | Procurement Director OR Strategic Sourcing Manager OR Supply Chain Director OR Quality Director OR Regulatory Affairs Director OR Business Development Director OR Partnerships Director OR CIO OR IT Director | Capture pharma buying and influencer roles |
| Geography | Saudi Arabia; GCC; Middle East; Africa; MENA; United Arab Emirates; Qatar; Kuwait; Bahrain; Oman; Egypt | Target likely visitor origin markets |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,000+ | Cover mid-market through enterprise pharma organizations |
| Keywords | pharma, pharmaceutical, API, excipients, packaging, drug delivery, CDMO, biologics, biosimilars, generics, cold chain, supply chain, regulatory, GMP | Improve precision for event-aligned searches |
| Company type | Public company; private company; subsidiary; enterprise | Prioritize organizations with buying authority and budget |
| Revenue range | $10M+ where applicable; especially $100M+ | Focus on companies with sustained sourcing and partnership needs |
| Technologies | ERP, supply chain systems, quality management systems, CRM, analytics platforms | Useful when selling digital, compliance, or workflow solutions |
Suggested Apollo Search Logic: (industry: Pharmaceuticals OR Biotechnology OR Medical Devices OR Government Administration) AND (title: Procurement OR Sourcing OR Supply Chain OR Quality OR Regulatory OR Business Development OR Partnerships) AND (location: Saudi Arabia OR GCC OR Middle East OR Africa) AND (seniority: Manager OR Director OR VP OR C-Level) AND keywords:(pharma OR API OR excipients OR packaging OR CDMO OR biologics OR biosimilars OR generics OR cold chain).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| CPhI Middle East official event page | Official organizer website | Event dates, venue, city, country, organizer branding, speaker presence, exhibitor count, visitor count, countries represented, and event positioning | Very High |
| CPhI global brand home page | Official brand / organizer site | Global brand context, community positioning, and year-round pharma network framing | Very High |
| About the brand – CPhI | Official organizer page | Brand mission, pharma community positioning, and event ecosystem framing | High |
| Why attend page | Official organizer page | Attendee value proposition, networking, and market access relevance | High |
| 2026 exhibitor list | Official event directory | Potential supplier ecosystem and account mapping basis where available | High |
| 2026 speakers page | Official event agenda / speaker page | Confirmed speaker organizations used for buyer-fit and stakeholder mapping | High |
| Plan your visit | Official organizer page | Venue naming, location context, and attendee logistics | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to CPhI Middle East & Africa — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds